Related Experiment Video
Updated: Oct 29, 2025

08:07
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
925
Quantitative paper-based dot blot assay for spike protein detection using fuchsine dye-loaded polymersomes
Faezeh Ghorbanizamani1, Hichem Moulahoum1, Figen Zihnioglu1
1Department of Biochemistry, Faculty of Science, Ege University, 35100-Bornova, Izmir, Turkey.
Biosensors & Bioelectronics
|July 11, 2021
Summary
We developed a novel polymersome assay for COVID-19 spike protein detection. This colorimetric, smartphone-assisted diagnostic tool offers high sensitivity and adaptability for point-of-care use.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Diagnostic Assays
Background:
- Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) is the gold standard for viral diagnosis.
- Point-of-care (POC) diagnostic technologies are advancing rapidly.
- Existing nanoparticle-based assays face limitations in cost and accessibility.
Purpose of the Study:
- To develop a novel fuchsine dye-loaded polymersome for a colorimetric paper-based dot blot assay.
- To create an adaptable diagnostic tool for COVID-19 spike protein detection using smartphone-assisted sensing.
- To provide a cost-effective and sensitive alternative to traditional nanoparticle assays.
Main Methods:
- Fabrication of fuchsine dye-loaded polymersomes.
- Development of a paper-based dot blot assay for COVID-19 spike protein.
- Utilizing smartphone-assisted sensing for colorimetric detection.
- Analytical characterization and performance evaluation.
Main Results:
- The polymersome-based assay demonstrated high sensitivity, surpassing gold nanoparticles by 10 times.
- The platform exhibited excellent stability, fast turnaround time, and reproducibility.
- Smartphone-assisted sensing enabled user-friendly, at-home testing capabilities.
Conclusions:
- The developed polymersome platform offers a sensitive, stable, and adaptable diagnostic tool for COVID-19.
- This technology has the potential for widespread application in resource-limited settings and home-based testing.
- The adaptable nature of the platform suggests utility for detecting various biomarkers and pathologies.

